Genetic Testing for Blood Cancer
Supplier Details
CapitalBio Technology Co., Ltd.
Free Member (2023)
[ Beijing, BE,China ]
Business Type: Manufacturer
Supplier has 5 products
Product Description
This test can detect SNV, Indel, and FLT3-ITD information of 232 genes associated with blood cancers, covers all types of leukemia - AML/ALL/CML/CLL/MDS/MPN and various lymphomas.
Applications of blood based cancer diagnostics
Provide comprehensive information related to diagnosis, prognosis, treatment and medication to assist clinical diagnosis and treatment.
For commonly used chemotherapeutic drugs, targeted drugs, demethylation drugs and supportive care drugs, this test will analyze the toxicity, side effects, efficacy, dose, and drug resistance, and evaluate the drug metabolism status of patients.
For more information about blood cancer therapy and microfluidic chip, please feel free to contact us!
There are many rna sequencing companies, but we are one of the best choices for you.
Basic Information
Country:
China
Business Type:
Manufacturer
Year Established:
2010
Total Employees:
51 - 100
About Us
CapitalBio Technology Co., Ltd. abbreviated “CapitalBio” is the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. CapitalBio has always adhered to independent innovation and achievement transformation and has a complete industrial chain integrating RD, production, sales, and thrid-party independent medical laboratory services; and responds to the national policy of “prevention first.” The health policy integrates modern medicine and traditional Chinese medicine to form a large health industry section that includes health products, health management, medical rehabilitation, and big data.
Member History
Year Joined:
2023
Membership Type:
Free Member
Send Supplier a Message
You must be signed in to contact this supplier.
